Skip to main content
SleepCited

CBD per Problemi di sonno legati all'ansia

A Evidenze Più grandi trial clinici mostrano in modo costante benefici significativi.

Basato su 35 studi (5 meta-analyses, 11 RCTs) con 17,358 partecipanti totali. 19/35 studi mostrano effetti positivi.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dcbd\u0026condition\u003Danxiety\u002Drelated\u002Dsleep'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

In sintesi

CBD may support better sleep in people whose rest is disrupted by anxiety, though results are mixed and the best dose and formulation are still being studied.

  • 35 studies with 17,358 participants — the largest evidence base among anxiety-sleep supplements
  • Roughly 54% of studies show positive effects, with others showing mixed results
  • May work through 5-HT1A serotonin receptors to reduce anxiety and promote sleep
  • Dosing varies widely across studies (25 mg to 300+ mg), making direct comparisons difficult

Key Study Findings

Other
Development of a novel Δ9-THC-specific color test reagent.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: Lab study: novel THC-specific color test reagent

Observational Study
Trends in burden and mortality of congenital birth defects in G20 countries (1990-2021) and predictions …
Dose: None vs: None Outcome: DALYs and mortality rates of congenital birth defects Effetto: DALYs decreased 59.77%, deaths decreased 63.81% None

Popolazione: G20 countries population, 1990-2021

Other
Policy reform and the international future of Moroccan Cannabis production.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

Observational Study n=126
The use of complementary and alternative medicine among cancer patients in Hawaii.
Dose: None vs: None Outcome: CAM therapy use patterns among cancer patients Effetto: 57.1% used at least one CAM therapy None

Popolazione: Cancer patients in Hawaii

Systematic Review
The Effect of Cannabidiol on Performance and Post-Load Recovery among Healthy and Physically Active Individuals: …
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: Healthy adults

Other 5 weeks
Dietary Cannabidiol Activates PKA/AMPK Signaling and Attenuates Chronic Inflammation and Leaky Gut in DSS-Induced Colitis …
Dose: 200 mg vs: None Outcome: Colitis severity Effetto: None None

Popolazione: Mouse model

Key Statistics

35

Studi

1794

Partecipanti

Mixed

A

Grado

Referenced Papers

Forensic toxicology 2025 1 citazioni
The International journal … 2025 1 citazioni
Proceedings. IEEE International … 2021 29 citazioni
Cureus 2020 23 citazioni
Nutricion hospitalaria 2015 161 citazioni
Current osteoporosis reports 2013 43 citazioni
Adolescent medicine: state … 2013 3 citazioni
Occupational medicine (Oxford, … 2012 33 citazioni
The Urologic clinics … 2002 20 citazioni
European journal of … 1989

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

sleep:
25-150 mg, 1 hour before bed

Limite massimo: Not established; FDA max studied ~20 mg/kg/day

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Mixed 126
None -- Positive --
200 mg 5 weeks Positive --
cannabidiol (CBD) at various doses administered to mice -- Positive --
None -- Positive --

Momento migliore per l'assunzione: 1 hour before bed

Safety & Side Effects

Effetti collaterali segnalati

  • Fatigue
  • Diarrhea
  • Changes in appetite
  • Dry mouth
  • Liver enzyme elevation at high doses

Interazioni note

  • CYP3A4/CYP2C19 substrates — CBD inhibits these liver enzymes
  • Blood thinners (warfarin) — CBD may increase warfarin levels
  • Clobazam — CBD significantly increases clobazam levels
  • Sedatives — additive drowsiness

Livello di assunzione massimo tollerabile: Not established; FDA max studied ~20 mg/kg/day

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does CBD help with Problemi di sonno legati all'ansia?
Based on 35 studies with 1,794 participants, there is strong evidence from multiple clinical trials that CBD may support Problemi di sonno legati all'ansia management. Our evidence grade is A (Strong Evidence).
How much CBD should I take for Problemi di sonno legati all'ansia?
Studies have used various dosages. A commonly studied range is 25-150 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of CBD?
Reported side effects may include Fatigue, Diarrhea, Changes in appetite, Dry mouth. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for CBD and Problemi di sonno legati all'ansia?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 35 peer-reviewed studies with 1,794 total participants. The overall direction of effect is mixed.

CBD per altre condizioni

References

  1. [1] Xiangwen Li et al.. BMC Pregnancy Childbirth. 2025. Trends in burden and mortality of congenital birth defects in G20 countries (1990-2021) and predictions for 2022-2040. doi:10.1186/s12884-025-07617-w PubMed
  2. [2] Kenji Tsujikawa et al.. Forensic Toxicol. 2025. Development of a novel Δ9-THC-specific color test reagent. doi:10.1007/s11419-025-00727-2 PubMed
  3. [3] Pierre-Arnaud Chouvy. Int J Drug Policy. 2025. Policy reform and the international future of Moroccan Cannabis production. doi:10.1016/j.drugpo.2025.104841 PubMed
  4. [4] April Hamachi et al.. BMC Complement Med Ther. 2025. The use of complementary and alternative medicine among cancer patients in Hawaii. doi:10.1186/s12906-025-04912-z PubMed
  5. [5] Qingchen Zhang et al.. Med Cannabis Cannabinoids. 2024. Pharmacokinetic Variability of Oral Cannabidiol and Its Major Metabolites after Short-Term High-Dose Exposure in Healthy Subjects. doi:10.1159/000535726 PubMed
  6. [6] Qi Sun et al.. Mol Nutr Food Res. 2024. Dietary Cannabidiol Activates PKA/AMPK Signaling and Attenuates Chronic Inflammation and Leaky Gut in DSS-Induced Colitis Mice. doi:10.1002/mnfr.202300446 PubMed
  7. [7] Yu-Meng Liu et al.. Neurochem Res. 2024. Cannabidiol Exerts Sedative and Hypnotic Effects in Normal and Insomnia Model Mice Through Activation of 5-HT1A Receptor. doi:10.1007/s11064-024-04102-2 PubMed
  8. [8] Mengxue He et al.. Cannabis Cannabinoid Res. 2024. Multi-Omics Reveals the Effects of Cannabidiol on Gut Microbiota and Metabolic Phenotypes. doi:10.1089/can.2022.0331 PubMed
  9. [9] Ali Niklewicz et al.. Nutr Bull. 2024. A systematic review and meta-analysis of functional vitamin B12 status among adult vegans. doi:10.1111/nbu.12712 PubMed
  10. [10] Dominika Szkopek et al.. Int J Mol Sci. 2024. Interaction Between Peroxisome Proliferator-Activated Receptors and Cannabidiol in the Gut of Chickens Applied to Different Challenge Conditions. doi:10.3390/ijms252111398 PubMed
  11. [11] Pedro González-Parejo et al.. Nutrients. 2024. Effects of Dietary Supplementation in Patients with Restless Legs Syndrome: A Systematic Review. doi:10.3390/nu16142315 PubMed
  12. [12] Eduard Bezuglov et al.. Nutrients. 2024. The Effect of Cannabidiol on Performance and Post-Load Recovery among Healthy and Physically Active Individuals: A Systematic Review. doi:10.3390/nu16172840 PubMed
  13. [13] Shelby Coates et al.. Pharmaceutics. 2024. Evaluation of the Drug-Drug Interaction Potential of Cannabidiol Against UGT2B7-Mediated Morphine Metabolism Using Physiologically Based Pharmacokinetic Modeling. doi:10.3390/pharmaceutics16121599 PubMed
  14. [14] Karin Ried et al.. J Sleep Res. 2023. Medicinal cannabis improves sleep in adults with insomnia: a randomised double-blind placebo-controlled crossover study. doi:10.1111/jsr.13793 PubMed
  15. [15] Kedar N Prasad. Mech Ageing Dev. 2023. A micronutrient mixture with collagen peptides, probiotics, cannabidiol, and diet may reduce aging, and development and progression of age-related alzheimer's … doi:10.1016/j.mad.2022.111757 PubMed
  16. [16] L Heilfort et al.. Nutr Cancer. 2023. A Systematic Review of the Benefit of B-Vitamins as a Complementary Treatment in Cancer Patients. doi:10.1080/01635581.2022.2098348 PubMed
  17. [17] Anne-Lise Bjørke-Monsen et al.. Food Nutr Res. 2023. Vitamin B6: a scoping review for Nordic Nutrition Recommendations 2023. doi:10.29219/fnr.v67.10259 PubMed
  18. [18] Aixing Pan et al.. J Pers Med. 2023. Apical Vertebras Distribution Modifier for Coronal Balance Classification in Adult Idiopathic Scoliosis. doi:10.3390/jpm13060897 PubMed
  19. [19] Roland Grad et al.. Am Fam Physician. 2023. Top 20 Research Studies of 2022 for Primary Care Physicians. PubMed
  20. [20] Amer Haffar et al.. J Arthroplasty. 2022. Topical Cannabidiol (CBD) After Total Knee Arthroplasty Does Not Decrease Pain or Opioid Use: A Prospective Randomized Double-Blinded Placebo-Controlled Trial. doi:10.1016/j.arth.2022.03.081 PubMed
  21. [21] Mohammad Soleymanpour et al.. Proceedings (IEEE Int Conf Bioinformatics Biomed). 2021. Therapeutic Claims in Cannabidiol (CBD) Marketing Messages on Twitter. doi:10.1109/bibm52615.2021.9669404 PubMed
  22. [22] Francis Lovecchio et al.. Int J Spine Surg. 2021. Prevalence of Cannabidiol Use in Patients With Spine Complaints: Results of an Anonymous Survey. doi:10.14444/8087 PubMed
  23. [23] Joseph J Wakshlag et al.. Vet Med (Auckl). 2020. Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements. doi:10.2147/VMRR.S248712 PubMed
  24. [24] Jessica Bass et al.. Cureus. 2020. A Case of Toxicity from Cannabidiol Gummy Ingestion. doi:10.7759/cureus.7688 PubMed
  25. [25] Dominique Endres et al.. Brain Sci. 2020. Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies. doi:10.3390/brainsci10060399 PubMed
  26. [26] Justine A Kavle et al.. Public Health Nutr. 2018. Community-based distribution of iron-folic acid supplementation in low- and middle-income countries: a review of evidence and programme implications. doi:10.1017/S1368980017002828 PubMed
  27. [27] Gabriela Gutiérrez-Salmeán et al.. Nutr Hosp. 2015. NUTRITIONAL AND TOXICOLOGICAL ASPECTS OF SPIRULINA (ARTHROSPIRA). doi:10.3305/nh.2015.32.1.9001 PubMed
  28. [28] Karin M A Swart et al.. Curr Osteoporos Rep. 2013. Vitamin B12, folic acid, and bone. doi:10.1007/s11914-013-0155-2 PubMed
  29. [29] Jenna X Cheng et al.. Adolesc Med State Art Rev. 2013. Considering biomedical/CAM treatments. PubMed
  30. [30] Health Quality Ontario. Ont Health Technol Assess Ser. 2013. Vitamin B12 and cognitive function: an evidence-based analysis. PubMed
  31. [31] A Seidler et al.. Occup Med (Lond). 2012. Systematic review: Progression of beryllium sensitization to chronic beryllium disease. doi:10.1093/occmed/kqs069 PubMed
  32. [32] Ethan M Balk et al.. Arch Intern Med. 2007. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. doi:10.1001/archinte.167.1.21 PubMed
  33. [33] Sue Wilson et al.. Prehosp Emerg Care. 2002. A systematic review of the evidence supporting the use of priority dispatch of emergency ambulances. doi:10.1080/10903120290938760 PubMed
  34. [34] Ashish M Kamat et al.. Urol Clin North Am. 2002. Chemoprevention of bladder cancer. doi:10.1016/s0094-0143(02)00022-8 PubMed
  35. [35] D A Bender. Eur J Clin Nutr. 1989. Vitamin B6 requirements and recommendations. PubMed

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.